mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.009 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.009 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.009 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |